FLAVONOID ADMINISTRATION IMPROVES ARTERIAL WALL PROPERTIES IN HEALTHY SMOKERS  by Kokkou, Eleni et al.
E2017
JACC March 12, 2013
Volume 61, Issue 10
Vascular Medicine 
flavonoid adminisTraTion improves arTerial wall properTies in healThy smokers
Oral Contributions
West, Room 3005
Saturday, March 09, 2013, 8:15 a.m.-8:30 a.m.
Session Title: Vascular Medicine: New Insights in Arterial Disease
Abstract Category: 35. Vascular Medicine: Non Coronary Arterial Disease
Presentation Number: 911-4
Authors: Eleni Kokkou, Gerasimos Siasos, Dimitris Tousoulis, Evangelos Oikonomou, Maria Eleni Kollia, Alexios Verveniotis, Stamatios Kioufis, 
Nikolaos Gouliopoulos, Marina Zaromitidou, Panagiotis Tourikis, Konstantinos Zisimos, Georgios Marinos, Athanasios Papavassiliou, Christodoulos I 
Stefanadis, 1st Cardiology Department, University of Athens Medical School, “Hippokration” Hospital, Athens, Greece
Background: Endothelial function and arterial compliance are surrogate markers of arterial health. Smoking is associated with impaired vascular 
function. In the present study we examined the impact of Concord grape juice (CGJ), a rich source of flavonoids, on endothelial function and arterial 
stiffness in healthy smokers under baseline conditions and after acute smoking.
methods: We studied the effect of a 2 weeks oral treatment with 7cc/Kg/day of CGJ (100% Concord Grape) in 26 healthy smokers (aged 26±5y) 
on three occasions (day 0: baseline, day 7 and day 14). The study was carried out on two separate arms, one with CGJ and one with placebo, 
according to a randomized, placebo-controlled, double-blind, cross-over design. Measurements were carried out before (pSm), immediately and 20 
minutes after cigarette smoking. Endothelial function was evaluated by flow-mediated dilation (FMD) of the brachial artery. Carotid-femoral pulse 
wave velocity (PWV) was measured as an index of aortic stiffness.
results: At day 0, FMD was significantly decreased immediately after smoking, and remained lower than baseline 20 min after smoking for 
both CGJ and placebo group (p<0.001 for both). Moreover, treatment with CGJ improved FMD in pSm measurements (from 8.35±2.83% day 0 to 
9.15±4.21% day 7 to 9.49±2.74% day 14, p=0.02) while there was not such improvement in FMD values at the placebo arm (p=0.31). Importantly, 
compared to placebo, CGJ treatment prevented the acute smoking induced decrease in FMD in day 7 (p=0.07) and in day 14 (p=0.04). Concerning 
arterial stiffness, at day0, smoking induced a significant elevation of PWV for both CGJ and placebo group (p<0.05). CGJ treatment resulted in a 
significant improvement in pSm values of PWV (from 6.13±0.61m/sec day 0 to 5.86±0.63m/sec day 7 to 5.63±0.56m/sec day 14, p=0.04) while 
there was no such improvement in the placebo arm (p=0.78). Finally, treatment with CGJ prevented also the smoking induced elevation of PWV, after 
7 (p=0.05) and 14 (p=0.04) days of treatment.
conclusions: CGJ consumption improved endothelial function and vascular elastic properties of the arterial tree in healthy smokers and 
attenuated acute smoking induced impairment of arterial wall properties.
